ID
45595
Beskrivning
Principal Investigator: Louis Fiore, MD, VA Boston Healthcare System, Boston, MA, USA MeSH: Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001374 The Research for Precision Oncology Program (RePOP) is a research activity that establishes a cohort of Veterans diagnosed with cancer and who have had genomic analyses performed on their tumor tissue as part of standard of care. All data relevant to a patient's cancer and cancer care will be collected under RePOP, including patient demographics, co-morbidities, genomic analysis, treatments, medications, lab values, imaging studies, and outcomes. All RePOP participants will have signed/verbal informed consent and signed HIPAA authorization to have their data stored and shared from RePOP's Precision Oncology Program Data Repository (PODR). The Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) network is a collaboration between NCI, the Department of Defense (DoD), and the Department of Veterans Affairs (VA) to incorporate proteogenomics into patient care as a way of looking beyond the genome, to the activity and expression of the proteins that the genome encodes. The emerging field of proteogenomics aims to better predict how patients will respond to therapy by screening their tumors for both genetic abnormalities and protein information, an approach that has been made possible in recent years due to advances in proteomic technology.
Länk
Nyckelord
Versioner (1)
- 2023-02-07 2023-02-07 - Simon Heim
Rättsinnehavare
Louis Fiore, MD, VA Boston Healthcare System, Boston, MA, USA
Uppladdad den
7 februari 2023
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs001374 VA APOLLO Project - Research for Precision Oncology (RePOP)
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
C0680251 (UMLS CUI [1,2])
C0035168 (UMLS CUI [1,2])
C1706245 (UMLS CUI [1,3])
C0027651 (UMLS CUI [1,4])
C0920688 (UMLS CUI [1,5])
C0521093 (UMLS CUI [1,6])
C0030664 (UMLS CUI [1,7])
C0184603 (UMLS CUI [1,8])
C0025102 (UMLS CUI [1,9])
C0006826 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C0205210 (UMLS CUI [1,4])
C0205547 (UMLS CUI [1,5])
C0599788 (UMLS CUI [1,2])
C1999230 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
Inga kommentarer